Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial

Authors:

Abstract
No abstract available

This publication has 27 references indexed in Scilit: